Lilly/BI's Jardiance Scores A Win In Heart Failure Where Rivals Have Not

Heart EKG
Jardiance showed a benefit in HFpEF in a Phase III trial • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapeutic Category